Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (53,244) $ (54,445)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,391 919
Non-cash interest expense 9,581 7,053
Share-based compensation expense 3,816 10,166
Provision for losses on receivables and inventory 511 3
Change in fair value of warrant and derivative liabilities 5,043 9,455
Amortization of operating right-of-use assets 378 279
Other non-cash, net 77  
Changes in operating assets and liabilities:    
Accounts receivable, net 13,072 1,992
Contract assets (5,017) 1,423
Inventory (1,309) (3,990)
Accounts payable 2,844 1,009
Contract liabilities 7,676 (8,021)
Reserve for anticipated losses on contracts (357) (1,723)
Accrued interest (49) (88)
Other, net (8,228) 3,145
Net cash used in operating activities (22,815) (32,823)
Cash flows from investing activities:    
Purchases of property, plant and equipment (2,498) (3,162)
Net cash used in investing activities (2,498) (3,162)
Cash flows from financing activities:    
Repayment of long-term debt (2,551) (518)
Payment of issuance costs (44)  
Proceeds from exercise of stock options 21 339
Net cash used in financing activities (2,574) (179)
Effect of exchange rate fluctuations on cash and cash equivalents (75) 30
Net decrease in cash and cash equivalents (27,962) (36,134)
Cash and cash equivalents at beginning of period 71,663 93,561
Cash and cash equivalents at end of period 43,701 57,427
Non-cash investing and financing activities:    
Purchases of property, plant, and equipment not yet paid $ 405 5,265
Issuance costs not yet paid   $ 139